MR编号 | CZ/H/0801/002 |
---|
药品名称 | Octreotide Teva |
---|
活性成分 | - Octreotide acetate 20.0 mg
|
---|
剂型 | Powder and solvent for suspension for injection |
---|
上市许可持有人 | Teva B.V.
Swensweg 5, Haarlem
2031GA
Netherlands |
---|
参考成员国 - 产品名称 | Czechia (CZ) OCTREOTIDE TEVA |
---|
互认成员国 - 产品名称 | - Denmark (DK)
- Belgium (BE)
Octreoteva Long Acting 20 mg poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte - Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
Octreoanne 20 mg stungulyfsstofn og leysir, forðadreifa - United Kingdom (Northern Ireland) (XI)
Octreotide LAI Teva - Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
Octreoanne - Finland (FI)
- Poland (PL)
Okteva - Lithuania (LT)
Octreotide Teva 20 mg milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai - Estonia (EE)
OCTREOTIDE TEVA - Hungary (HU)
OKTREOTID TEVA 20 mg por és oldószer retard szuszpenziós injekcióhoz - Bulgaria (BG)
Octreotide LAI Teva - Romania (RO)
- Slovenia (SI)
- Croatia (HR)
Oktreotid Teva 20 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem
|
---|
许可日期 | 2019/04/16 |
---|
最近更新日期 | 2024/12/16 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|